Rapamycin inhibits telomerase activity by decreasing the hTERT mRNA level in endometrial cancer cells

Molecular Cancer Therapeutics

Volumn 2, Issue 8, 2003, Pages 789-795

  Zhou, Chunxiao ^a   Gehrig, Paola A ^a,b   Whang, Young E ^a,b   Boggess, John F ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; DNA BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PROTEIN KINASE; RAPAMYCIN; TELOMERASE;

APOPTOSIS; ARTICLE; CELL CYCLE; DRUG ANTAGONISM; DRUG EFFECT; ENDOMETRIUM TUMOR; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; METABOLISM; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; PROTEIN KINASES; RNA, MESSENGER; SIGNAL TRANSDUCTION; SIROLIMUS; TELOMERASE;

EID: 2342483301     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Abraham, R. T. Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling. Curr. Opin. Immunol., 10: 330-336, 1998. (Pubitemid 28286960)
2. Schmelzle, T., and Hall, M. N. TOR, a central controller of cell growth. Cell, 103: 253-262, 2000.
3. Raught, B., Gingras, A. C., and Sonenberg, N. The target of rapamycin (TOR) proteins. Proc. Natl. Acad. Sci. USA, 98: 7037-7044, 2001. (Pubitemid 32567899)
4. Hidalgo, M., and Rowinsky, E. K. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene, 19: 6680-6686, 2000. (Pubitemid 32197708)
5. Huang, S., and Houghton, P. J. Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic. Curr. Opin. Investig. Drugs, 3: 295-304, 2002. (Pubitemid 34456089)
6. Mills, G. B., Lu, Y., and Kohn, E. C. Linking molecular therapeutics to molecular diagnostics: inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and invivo. Proc. Natl. Acad. Sci. USA, 98: 10031-10033, 2001. (Pubitemid 32802967)
7. Stewart, S. A., and Weinberg, R. A. Telomerase and human tumorigenesis. Semin. Cancer Biol., 10: 399-406, 2000. (Pubitemid 32181910)
8. Cong, Y. S., Wright, W. E., and Shay, J. W. Human telomerase and its regulation. Microbiol. Mol. Biol. Rev., 66: 407-425, 2002. (Pubitemid 35001137)
9. Jemal, A., Thomas, A., Murray, T., and Thun, M. Cancer statistics, 2002. CA Cancer J. Clin., 52: 23-47, 2002. (Pubitemid 34110469)
10. Mutter, G. L., Lin, M. C., Fitzgerald, J. T., Kum, J. B., Baak, J. P., Lees, J. A., Weng, L. P., and Eng, C. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J. Natl. Cancer Inst. (Bethesda), 92: 924-930, 2000.
11. Cantley, L. C., and Neel, B. G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. USA, 96: 4240-4245, 1999. (Pubitemid 29190320)
12. Williams, C. D., Boggess, J. F., LaMarque, L. R., Meyer, W. R., Murray, M. J., Fritz, M. A., and Lessey, B. A. A prospective, randomized study of endometrial telomerase during the menstrual cycle. J. Clin. Endocrinol. Metab., 86: 3912-3917, 2001. (Pubitemid 32755997)
13. Holt, S. E., Norton, J. C., Woodring, W. E., and Shay, J. W. Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit. Methods Cell Sci., 18: 237-248, 1996. (Pubitemid 26345354)
14. Bieche, I., Nogues, C., Paradis, V., Olivi, M., Bedossa, P., Lidereau, R., and Vidaud, M. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin. Cancer Res., 6: 452-459, 2000. (Pubitemid 30111463)
15. Brown, E. J., Beal, P. A., Keith, C. T., Chen, J., Shin, T. B., and Schreiber, S. L. Control of p70 s6 kinase by kinase activity of FRAP in vivo.Nature (Lond.), 377: 441-446, 1995.
16. Jefferies, H. B., Fumagalli, S., Dennis, P. B., Reinhard, C., Pearson, R. B., and Thomas, G. Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k. EMBO J., 16: 3693-3704, 1997. (Pubitemid 27250062)
17. Romanelli, A., Dreisbach, V. C., and Blenis, J. Characterization of phosphatidylinositol 3-kinase-dependent phosphorylation of the hydrophobic motif site Thr389 in p70 S6 kinase 1. J. Biol. Chem., 277: 40281-40289, 2002. (Pubitemid 35215600)
18. Ferrari, S., Bandi, H. R., Hofsteenge, J., Bussian, B. M., and Thomas, G. Mitogen-activated 70K S6 kinase. Identification of in vitro 40 S ribosomal S6 phosphorylation sites. J. Biol. Chem., 266: 22770-22775, 1991.
19. Gingras, A. C., Raught, B., and Sonenberg, N. Regulation of translation initiation by FRAP/mTOR. Genes Dev., 15: 807-826, 2001. (Pubitemid 32295062)
20. Gingras, A. C., Gygi, S. P., Raught, B., Polakiewicz, R. D., Abraham, R. T., Hoekstra, M. F., Aebersold, R., and Sonenberg, N. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev., 13:1422-1437, 1999. (Pubitemid 29270247)
21. Podsypanina, K., Lee, R. T., Politis, C., Hennessy, I., Crane, A., Puc, J., Neshat, M., Wang, H., Yang, L., Gibbons, J., Frost, P., Dreisbach, V., Blenis, J., Gaciong, Z., Fisher, P., Sawyers, C., Hedrick-Ellenson, L., and Parsons, R. An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice. Proc. Natl. Acad. Sci. USA, 98:10320-10325, 2001. (Pubitemid 32803018)
22. Neshat, M. S., Mellinghoff, I. K., Tran, C., Stiles, B., Thomas, G., Petersen, R., Frost, P., Gibbons, J. J., Wu, H., and Sawyers, C. L. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. Proc. Natl. Acad. Sci. USA, 98: 10314-10319, 2001. (Pubitemid 32803017)
23. Shi, Y., Gera, J., Hu, L., Hsu, J. H., Bookstein, R., Li, W., and Lichtenstein, A. Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779. Cancer Res., 62: 5027-5034, 2002. (Pubitemid 34984430)
24. Grunwald, V., DeGraffenried, L., Russel, D., Friedrichs, W. E., Ray, R. B., and Hidalgo, M. Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells. Cancer Res., 62:6141-6145, 2002. (Pubitemid 35244463)
25. Sakurada, A., Hamada, H., Fukushige, S., Yokoyama, T., Yoshinaga, K., Furukawa, T., Sato, S., Yajima, A., Sato, M., Fujimura, S., and Horii, A. Adenovirus-mediated delivery of the PTEN gene inhibits cell growth by induction of apoptosis in endometrial cancer. Int. J. Oncol., 15: 1069-1074, 1999.
26. Yu, K., Toral-Barza, L., Discafani, C., Zhang, W. G., Skotnicki, J., Frost, P., and Gibbons, J. J. mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer. Endocr. Relat. Cancer, 8: 249-258, 2001. (Pubitemid 32947647)
27. Zhu, X., Kumar, R., Mandal, M., Sharma, N., Sharma, H. W., Dhingra, U., Sokoloski, J. A., Hsiao, R., and Narayanan, R. Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc. Natl. Acad. Sci. USA, 93: 6091-6095, 1996. (Pubitemid 26190808)
28. Holt, S. E., Aisner, D. L., Shay, J. W., and Wright, W. E. Lack of cell cycle regulation of telomerase activity in human cells. Proc. Natl. Acad. Sci. USA, 94: 10687-10692, 1997. (Pubitemid 27430795)
29. Cardenas, M. E., Cutler, N. S., Lorenz, M. C., Di Como, C. J., and Heitman, J. The TOR signaling cascade regulates gene expression in response to nutrients. Genes Dev., 13: 3271-3279, 1999. (Pubitemid 30030448)
30. Hardwick, J. S., Kuruvilla, F. G., Tong, J. K., Shamji, A. F., and Schreiber, S. L. Rapamycin-modulated transcription defines the subset of nutrient-sensitive signaling pathways directly controlled by the Tor proteins. Proc. Natl. Acad. Sci. USA, 96: 14866-14870, 1999. (Pubitemid 30019731)
31. Beck, T., and Hall, M. N. The TOR signalling pathway controls nuclear localization of nutrient-regulated transcription factors. Nature (Lond.), 402:689-692, 1999. (Pubitemid 129516342)
32. Yokogami, K., Wakisaka, S., Avruch, J., and Reeves, S. A. Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr. Biol., 10: 47-50, 2000. (Pubitemid 30057415)
33. Bruemmer, D., Yin, F., Liu, J., Kiyono, T., Fleck, E., Van Herle, A. J., and Law, R. E. Rapamycin inhibits E2F-dependent expression of minichromosome maintenance proteins in vascular smooth muscle cells. Biochem. Biophys. Res. Commun., 303: 251-258, 2003. (Pubitemid 36338233)
34. Laughner, E., Taghavi, P., Chiles, K., Mahon, P. C., and Semenza, G. L. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol., 21: 3995-4004, 2001. (Pubitemid 32476461)
35. Hudson, C. C., Liu, M., Chiang, G. G., Otterness, D. M., Loomis, D. C., Kaper, F., Giaccia, A. J., and Abraham, R. T. Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin. Mol. Cell. Biol., 22: 7004-7014, 2002.
36. Dudkin, L., Dilling, M. B., Cheshire, P. J., Harwood, F. C., Hollingshead, M., Arbuck, S. G., Travis, R., Sausville, E. A., and Houghton, P. J. Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibition. Clin. Cancer Res., 7: 1758-1764, 2001. (Pubitemid 32708646)
37. Sekulic, A., Hudson, C. C., Homme, J. L., Yin, P., Otterness, D. M., Karnitz, L. M., and Abraham, R. T. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res., 60: 3504-3513, 2000. (Pubitemid 30482170)
38. Tee, A. R., Fingar, D. C., Manning, B. D., Kwiatkowski, D. J., Cantley, L. C., and Blenis, J. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc. Natl. Acad. Sci. USA, 99: 13571-13576, 2002. (Pubitemid 35215423)
39. 1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability. J. Biol. Chem., 273: 14424-14429, 1998.
40. Grewe, M., Gansauge, F., Schmid, R. M., Adler, G., and Seufferlein, T. Regulation of cell growth and cyclin D1 expression by the constitutively active FRAP-p70s6K pathway in human pancreatic cancer cells. Cancer Res., 59: 3581-3587, 1999. (Pubitemid 29381856)